<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="31923">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02094118</url>
  </required_header>
  <id_info>
    <org_study_id>13-005965</org_study_id>
    <nct_id>NCT02094118</nct_id>
  </id_info>
  <brief_title>Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications</brief_title>
  <official_title>Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Blood Systems Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to determine if point-of-care washing of allogeneic Leukocyte-Reduced
      Red Blood Cells reduces pulmonary complications when compared to standard-of-care
      Leukocyte-Reduced Red Blood Cells in a cardiac surgical population.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2015</start_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Developement of Transfusion Related Acute Lung Injury / Transfusion Associated Circulatory Overload</measure>
    <time_frame>Up to hospital day 28 or hosptial discharge, whichever comes first</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical Ventilation</measure>
    <time_frame>Up to hosptial day 28, or discharge, whichever comes first</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of oxygen supplementation</measure>
    <time_frame>Up to day 28, or hospital discharge, whichever comes first</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score</measure>
    <time_frame>Hosptial day 28 or discharge, whichever comes first</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Length of Stay</measure>
    <time_frame>Up to day 28</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">85</enrollment>
  <condition>Cardiac Surgical Patients</condition>
  <arm_group>
    <arm_group_label>Standard of care red blood cell transfusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Red Blood Cells that are administered in the normal fashion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Point-of-Care washed leukocyte-reduced red blood cells</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Red Blood Cells that are Leukocyte -reduced at the point-of-care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Point-of-care washed RBCs.</intervention_name>
    <arm_group_label>Point-of-Care washed leukocyte-reduced red blood cells</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Standard of Care Blood Transfusion</intervention_name>
    <arm_group_label>Standard of care red blood cell transfusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age equal to or greater than 18 years of age.

          -  Scheduled to have cardiac bypass surgery at Mayo Clinic in Rochester, MN or Duke
             University Medical Center in Raleigh, NC

          -  At risk for needing at least 4 units of blood during/after surgery
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daryl Kor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 20, 2014</lastchanged_date>
  <firstreceived_date>March 19, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Daryl J. Kor, M.D.</investigator_full_name>
    <investigator_title>Associate Professor of Anesthsiology</investigator_title>
  </responsible_party>
  <keyword>Transfusion</keyword>
  <keyword>RBC</keyword>
  <keyword>cardiac</keyword>
  <keyword>surgery</keyword>
  <keyword>TRALI</keyword>
  <keyword>TACO</keyword>
  <keyword>transfusion related acute lung injury</keyword>
  <keyword>transfusion associated circulatory overload</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
